BSG and ovarian carcinoma: According to the expression of CD147, 96 cases of ovarian cancer were divided into low (-/+) and high (++/+++) CD147 expression group, the results suggested that the high positive expression rate of CD147 in malignant group was 58.3% (56/96), which was higher than that in benign group (14.3%, [2/14]) and normal tissues (8.3%, [1/12]) (both P < 0.